SCHEMBL4911213

SCHEMBL4911213

CCCNc1c(-c2ccccc2OC)c(=O)c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 2/20 0.53
ITGA4 P13612 2/20 0.53
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
POLB P06746 1/20 0.45
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 3/20 0.44
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HTR1A P08908 2/20 0.41
HTR1D P28221 2/20 0.41
HTR1B P28222 2/20 0.41
HTR2A P28223 2/20 0.41
HTR7 P34969 2/20 0.41
HTR2B P41595 2/20 0.41
HTR5A P47898 2/20 0.41
HTR2C P28335 1/20 0.41
HTR6 P50406 1/20 0.41
FPR1 P21462 5/20 0.40
APP P05067 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4930517 0.88 KDM4E (0.51) ITGB1ITGA4MEN1KMT2APOLB
SCHEMBL4925114 0.79 MEN1 (0.42) ITGB1ITGA4MEN1KMT2APOLB
SCHEMBL7530457 0.73 ITGB1 (0.43) ITGB1ITGA4MEN1KMT2APOLB
SCHEMBL9509511 0.69 MEN1 (0.53) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL1644001 0.69 CHRM2 (0.64) ALDH1A1HPGDHTR1AMAPT
SCHEMBL7536229 0.68 CRHR1 (0.44) ITGB1ITGA4MEN1KMT2AALDH1A1
SCHEMBL22721651 0.68 ITGB1 (0.46) ITGB1ITGA4MEN1KMT2AALDH1A1
SCHEMBL10437520 0.67 ALDH1A1 (0.46) MEN1KMT2APOLBALDH1A1KDM4E
SCHEMBL13918748 0.67 GAA (0.41) ITGB1ITGA4ALDH1A1KDM4EMAPT
SCHEMBL24485285 0.67 CYP1A2 (0.39) ITGB1ITGA4MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234266-A1 Squaric Acid Derivatives II CHEK2, CHEK1, SGK3 ITGB1 4524/4885ITGA4 4722/4885MEN1 2856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.